Scheme 1
From: Poly(p-phenylenevinylene) nanoparticles modified with antiEGFRvIII for specific glioblastoma therapy
(a) Illustrated preparation of antibody-modified nanoparticles (PPVN-A). (b) Schematic illustration of PPVN-A for targeted photodynamic therapy.
